- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07906483
Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery After Abdominal Surgery
The Effect of Baduanjin Exercise on Pain, Fatigue, and Quality of Recovery in Patients Undergoing Abdominal Surgery: A Randomized Controlled Trial
This randomized controlled trial aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery.
A total of 60 participants will be randomly assigned to an intervention group or a control group. Before surgery, participants in the intervention group will receive instruction in Baduanjin exercises and perform the exercises once to learn the technique. After hospital discharge, they will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise.
At the end of weeks 3 and 6, pain, fatigue, fatigue severity, and quality of recovery will be assessed using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. Outcomes will be compared between the intervention and control groups.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This study aims to evaluate the effects of Baduanjin exercise on pain, fatigue, fatigue severity, and quality of recovery in patients undergoing abdominal surgery. The study is planned as a randomized, controlled, pretest-posttest experimental study involving 60 patients undergoing abdominal surgery at Gümüşhane State Hospital, Türkiye. Participants will be randomly assigned to an intervention group (n=30) or a control group (n=30). Before surgery, participants in the intervention group will be taught how to perform Baduanjin exercises and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Participants in the control group will receive standard hospital care without Baduanjin exercise. At the end of weeks 3 and 6, outcomes will be assessed in both groups using the Visual Analog Scale (VAS) to measure pain intensity, the Fatigue Scale to assess fatigue, the Fatigue Severity Scale to assess fatigue severity, and the Quality of Recovery-40 (QoR-40) questionnaire to evaluate quality of recovery. The results will be compared between the intervention and control groups to determine the effects of the Baduanjin exercise program on pain, fatigue, fatigue severity, and quality of recovery following abdominal surgery.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: NİRAN ÇOBAN, Asst. prof.
- Numéro de téléphone: 05301586912
- E-mail: nirancoban@gmail.com
Sauvegarde des contacts de l'étude
- Nom: Nurşen Kulakaç, Assoc. Prof.
- E-mail: nrsnklkc@gmail.com
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients aged 18 years and older and younger than 70 years.
- Patients undergoing abdominal surgery.
- Patients who voluntarily agree to participate in the study and provide informed consent.
- Patients with a body mass index (BMI) below 40 kg/m².
- Patients with a Standardized Mini-Mental State Examination score of 24 or higher.
- Patients who are able to read and write.
Exclusion Criteria:
- Patients with communication or comprehension difficulties.
- Patients who receive sedation.
- Patients who have difficulty understanding or speaking Turkish.
- Patients with a psychiatric disorder who are receiving medication.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Standart care
Participants in this group will receive standard hospital care without Baduanjin exercise. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. |
|
|
Expérimental: Baduanjin Exercise Group
Participants in this group will receive instruction in Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. |
Participants in the intervention group will be taught Baduanjin exercises before surgery and will perform the exercises once under instruction to learn the technique. After hospital discharge, participants will continue the Baduanjin exercise program three days per week for six weeks. Pain, fatigue, fatigue severity, and quality of recovery will be assessed at the end of weeks 3 and 6 using the Visual Analog Scale (VAS), Fatigue Scale, Fatigue Severity Scale, and Quality of Recovery-40 (QoR-40), respectively. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
The Effect of Baduanjin on Pain
Délai: At the end of weeks 3 and 6 after hospital discharge.
|
Visual Analog Scale (VAS): The Visual Analog Scale (VAS) is a commonly used tool for assessing pain. It consists of a 10-cm (100-mm) line ranging from 0 (no pain) to 10 (worst imaginable pain). In this study, the VAS will be used to assess pain in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on pain. |
At the end of weeks 3 and 6 after hospital discharge.
|
|
The Effect of Baduanjin on Fatigue
Délai: At the end of weeks 3 and 6 after hospital discharge.
|
Fatigue Scale (FS): The Fatigue Scale was developed by Beurskens et al. in 2000 to assess chronic fatigue. The scale consists of 20 items and evaluates fatigue over the previous two weeks across four dimensions: subjective fatigue perception, concentration, motivation, and physical activity. The Turkish version was validated by Ergin et al. in 2009. The total score ranges from 20 to 140, with higher scores indicating greater chronic fatigue. In this study, the Fatigue Scale will be used to assess fatigue in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue. |
At the end of weeks 3 and 6 after hospital discharge.
|
|
The Effect of Baduanjin Exercise on Fatigue Severity
Délai: At the end of weeks 3 and 6 after hospital discharge.
|
Fatigue Severity Scale (FSS): The Fatigue Severity Scale was developed by Krupp et al. in 1989 to assess fatigue severity, initially in patients with multiple sclerosis and systemic lupus erythematosus. It consists of nine items assessing the subjective severity of fatigue during the previous week. Each item is rated on a seven-point scale, and the total score is calculated as the arithmetic mean of the item scores. Higher scores indicate greater fatigue severity, and a score of approximately 4 or above generally suggests substantial fatigue. The Turkish validity and reliability study was conducted by Gencay Can et al. in 2012. In this study, the Fatigue Severity Scale will be used to assess fatigue severity in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on fatigue severity. |
At the end of weeks 3 and 6 after hospital discharge.
|
|
The Effect of Baduanjin Exercise on Quality of Recovery
Délai: At the end of weeks 3 and 6 after hospital discharge.
|
Quality of Recovery-40 (QoR-40): The Quality of Recovery-40 (QoR-40) was developed by Myles et al. in 2000 and its Turkish validity and reliability were evaluated by Karaman et al. in 2014. The questionnaire consists of 40 items across five dimensions: emotional state, physical comfort, patient support, physical independence, and pain. Each item is rated on a five-point Likert scale, and the total score ranges from 40 to 200. Higher scores indicate better postoperative physical and emotional well-being, whereas lower scores indicate poorer quality of recovery. In this study, the QoR-40 will be used to assess quality of recovery in patients undergoing abdominal surgery at the end of weeks 3 and 6 after hospital discharge to evaluate the effect of Baduanjin exercise on postoperative recovery. |
At the end of weeks 3 and 6 after hospital discharge.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Directeur d'études: Nurşen Kulakaç, Assoc. Prof., Gümüşhane Universıty
Publications et liens utiles
Publications générales
- Wu D, Li J, Dong H, Zheng Y, Liu Z, Shen Y, Cui H. Effect of Baduanjin on postoperative activity tolerance, lung function and negative emotions in patients with lung cancer: a protocol for systematic review and meta-analysis. BMJ Open. 2025 May 19;15(5):e093152. doi: 10.1136/bmjopen-2024-093152.
- Wan Y, Fu Y, Bian Z, Wang C, Sun R, Lu Y, Lv H, Xuan L. Effects of traditional Chinese exercises for upper-limb dysfunction following breast cancer surgery: protocol for a systematic review and meta-analysis. BMJ Open. 2026 May 18;16(5):e112564. doi: 10.1136/bmjopen-2025-112564.
- Liu X, Hao X, Zhang W, Zhang F, Liu H. Baduanjin sequential therapy's effects on quality of life and cardiac function in post-cardiac surgery heart disease patients: A systematic review. Medicine (Baltimore). 2026 Jan 2;105(1):e46855. doi: 10.1097/MD.0000000000046855.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- NCNK
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .